References
- Babson A L. The Immulite automated immunoassay system. J Clin Immunoassay 1991; 14: 83–88
- Brawer M K, Schifman R B, Ahmann F R, Ahmann M E, Coulis K M. The effect of digital rectal examination on serum levels of prostatic-specific antigen. Arch Pathol Lab Med 1988; 112: 1110–1112
- Carter S SC, Patel A, Reddy P, Royer P, Ramsay J WA. Single-session transurethral microwave thermotherapy for the treatment of benign prostatic obstruction. J Endourol 1991; 5: 137–144
- Christensson A. Prostate-specific antigen. Enzyme activity and reactions with extracellular protease inhibitors. Thesis, University of Lund, Malmo 1993
- Christensson A, Bjork T, Nilsson O, et al. Serum prostate specific antigen complexed to al-antichy-motrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100–105
- Dahlstrand C, Aldenborg F, Pettersson S. Histological findings after microwave treatment (TUMT) of benign prostatic hyperplasia (BPH). Scand J Urol Nephrol 1994, (Suppl 161), abstract No. 27
- Devonec M, Berger N, Perrin P. Transurethral microwave heating of the prostate–or from hyperthermia to thermotherapy. J Endourol 1991; 5: 129–135
- Gormley G J. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327: 1185–1191
- Holmang S, Lindstedt G, Mårin P, Hedelin H. Serum concentration of prostate-specific antigen in relation to prostate volume in 50 healthy middle-aged men. Scand J Urol Nephrol 1993; 27: 15–20
- Hughes H R, Penney M D, Ryan P G, Peeling W B. Serum prostatic specific antigen: in vitro stability and the effect of ultrasound rectal examination in vivo. Ann Clin Biochem 1987; 24(Suppl SI)206–208
- Leventhal E K, Rozanski T A, Morey A F, Rholl V. The effects of exercise and activity on serum prostate specific antigen levels. J Urol 1993; 150: 893–894
- Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899–1903
- Lilja H. Significance of different molecular forms of serum PSA–the free, noncomplexed form of PSA versus that complexed to α1-antichymotrypsin. Urol Clin North Am 1993; 20: 681–686
- Lilja H, Christensson A, Dahlen U, et al. Protease-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin. Clin Chem 1991; 37: 1618–1625
- Madsen P O, Iversen P. A point system for selecting operative candidates. Benign Prostatic Hypertrophy, F Hinman, Jr. Springer Verlag, New York 1983; 763–765
- Oesterling J E, Jacobsen S J, Klee G G, et al. Free, complexed and total serum prostate antigen: the establishment of appropriate reference ranges for their concentrations and ratios. J Urol 1995; 154: 1090–1095
- Oesterling J E, Rice D C, Glenski W J, Bergstralh E J. Effect of cystoscopy, prostate biopsy, and transurethral resection of prostate on serum prostate-specific antigen concentration. Urology 1993; 42: 276–282
- Romics I, Galamb L. Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients. Eur Urol 1992; 21(Suppl 1)83–86
- Simak R, Madersbacher S, Zhang Z-F, Maier U. The impact of ejaculation on serum prostate specific antigen. J Urol 1993; 150: 895–897
- Sinha A A, Wilson M J, Gleason D F. Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Cancer 1987; 60: 1288–1293
- Stamey T A, Yang N, Hay A R, McNeal J E, Freiha F S, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–916
- Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222–226
- Strohmaier W L, Fluchter S H, Wilbert D M, Bichler K H. Influence of transrectal hyperthermia on prostate-specific antigen in prostatic cancer and benign prostatic hyperplasia. Urol Int 1993; 51: 28–31
- Wilcoxon L. Individual comparisons by ranking methods. Biometrics Bull 1945; 1: 80